Загрузка...
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease
Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease...
Сохранить в:
Главные авторы: | , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2012
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594468/ https://ncbi.nlm.nih.gov/pubmed/23154587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.184 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|